Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Asahi Kasei, Evotec Enter Ion Channel Discovery Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Asahi Kasei, Evotec Enter Ion Channel Discovery Pact

Evotec will screen several ion channel targets

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evotec AG has entered into a multi-target screening collaboration with Asahi Kasei Pharma for several ion channel targets. Evotec will use its ion channel platform to identify inhibitors of multiple targets. Financial terms were not disclosed.
 
Dr. Mario Polywka, chief operating officer of Evotec, said, “We are extremely pleased that Asahi Kasei Pharma has decided to undertake these projects with Evotec. Our expertise and platform on ion channel drug discovery has proven to add significant value to our partner’s programs and we look forward to supporting Asahi Kasei Pharma in their own ion channel drug discovery efforts.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics